BRD2 and pancreatic neoplasm: These results indicate that the MAL (+) lymphocytes were in the intermediate differentiation stage of the T-cell lineage expressing transcription factors that induce CD8 differentiation or Th1 response, contributing to antitumor immunity by NAT in pancreatic cancer.